Raymond James analyst Andrew Cooper initiated coverage of Integer (ITGR) with an Outperform rating and $145 price target Integer is a contract development and manufacturing organization poised for continued growth, capitalizing on the shift in focus to areas like cardio and vascular, cardiac rhythm management, and neuromodulation that are “in the midst of innovation cycle benefits,” the analyst tells investors. Risks around insourcing and customer concentration are “more than reflected in the current valuation, which under-appreciates the double-digit growth in profitability,” the analyst added.
Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ITGR: